Association Asthma, Bulgaria   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Sofia Bulgaria (1998)

Organization Overview

First Clinical Trial
2011
NCT01250652
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Prof. Todor Popov

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cough (Phase 4)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Rhinitis, Allergic, Seasonal (Phase 4)

Urticaria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 12